Medication info
Telmisartan/Amlodipine 40/10mg

Telmisartan/Amlodipine 40/10mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
White or whitish rectangular tablet
Packaging
30 tablets (10 tablets/Alu-Alu * 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201606377 · Approved 2016.10.31 · Insurance code 665002190

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this drug, it is recommended that the dose of each individual component (amlodipine or telmisartan) be adjusted. However, switching directly to this drug may be considered when blood pressure is not controlled with the individual components, as follows: - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this drug 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: Although the usual amlodipine dosage is recommended for elderly patients, caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution During Administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication effectively manages blood pressure through combination therapy for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy using either amlodipine or telmisartan.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this drug, it is recommended that the dose of each individual component (amlodipine or telmisartan) be adjusted. However, switching directly to this drug may be considered when blood pressure is not controlled with the individual components, as follows: - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this drug 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: Although the usual amlodipine dosage is recommended for elderly patients, caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution During Administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, and should not be used during pregnancy. If pregnancy is confirmed, this medication should be discontinued immediately. It is contraindicated in individuals with allergies to this medication or similar compounds, women who are pregnant or may become pregnant, nursing women, patients with cholestatic disease, severe hepatic impairment, certain heart conditions, severe hypotension, patients in shock, patients unstable after acute myocardial infarction, those with genetic issues related to the excipients of this medication, and those with diabetes or severe kidney disease. It should be administered cautiously in certain patients, including those with primary aldosteronism, specific heart valve diseases, liver impairments, gastrointestinal diseases, renal artery hypertension, patients on dialysis, the elderly, and patients taking other medications that affect the renin-angiotensin-aldosterone system. Dizziness and peripheral edema are commonly observed when taking this medication, and rare side effects such as severe fainting may also occur, thus requiring caution. This medication should not be initiated or continued during pregnancy, and if planning for pregnancy or confirmation of pregnancy occurs, it should be replaced with other antihypertensive treatments proven to be safe. Due to the risk of hypotension, careful monitoring is especially necessary in patients who are volume-depleted or have insufficient salt intake, and regular checks of serum potassium levels are necessary due to the risk of hyperkalemia. In patients with impaired kidney function, regular monitoring of renal function is required, and caution is warranted as symptoms may worsen in patients with myocardial infarction or angina. This medication may cause drowsiness or dizziness, so caution is advised when driving or operating hazardous machinery. Interactions may occur when taken with other medications, especially digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, simvastatin, and tacrolimus, so consultation with a specialist and periodic monitoring is necessary. It is recommended to avoid taking this medication while nursing. The safety and efficacy in patients under 18 years of age have not been well established, and therefore its use is not recommended. When administered to the elderly, careful observation and dosage adjustment are necessary as sensitive reactions may occur. In cases of overdose, symptoms such as hypotension, tachycardia, dizziness, and acute kidney failure may appear, requiring immediate contact with medical institutions for appropriate treatment. This medication should be kept out of reach of children and should be taken out of its sealed packaging immediately before administration.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
Show 104 more
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • hypertonia
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • abdominal pain
  • indigestion
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic erythema
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • pollakiuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • positional vertigo

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that protects it from light, ideally at a temperature between 1°C and 30°C. Storing it this way maintains its efficacy and prevents degradation.

Appearance and packaging

Appearance

White or whitish rectangular tablet

Package unit

30 tablets (10 tablets/Alu-Alu * 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.